NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
0.980
+0.020 (2.12%)
At close: Mar 9, 2026, 4:00 PM EDT
0.950
-0.030 (-3.06%)
After-hours: Mar 9, 2026, 4:21 PM EDT
NanoViricides Market Cap
NanoViricides has a market cap or net worth of $21.16 million as of March 9, 2026. Its market cap has decreased by -6.77% in one year.
Market Cap
21.16M
Enterprise Value
15.57M
1-Year Change
-6.77%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since September 25, 2013, NanoViricides's market cap has decreased from $293.90M to $21.16M, a decrease of -92.80%. That is a compound annual growth rate of -19.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 20.70M | 1.97% |
| Dec 31, 2025 | 20.30M | -0.98% |
| Dec 31, 2024 | 20.50M | 70.83% |
| Dec 29, 2023 | 12.00M | -6.98% |
| Dec 30, 2022 | 12.90M | -69.93% |
| Dec 31, 2021 | 42.90M | 40.20% |
| Dec 31, 2020 | 30.60M | 215.46% |
| Dec 31, 2019 | 9.70M | -30.22% |
| Dec 31, 2018 | 13.90M | -75.04% |
| Dec 29, 2017 | 55.70M | -10.59% |
| Dec 30, 2016 | 62.30M | -8.38% |
| Dec 31, 2015 | 68.00M | -56.21% |
| Dec 31, 2014 | 155.30M | -35.32% |
| Dec 31, 2013 | 240.10M | -18.31% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daré Bioscience | 21.86M |
| IO Biotech | 21.62M |
| Lixte Biotechnology Holdings | 21.26M |
| Polyrizon | 20.90M |
| Reviva Pharmaceuticals Holdings | 20.87M |
| Lexaria Bioscience | 20.63M |
| Genenta Science | 20.15M |
| Intensity Therapeutics | 20.14M |